ABEONA THERAPEUTICS INC. — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Abeona Therapeutics filed an 8-K on 2026-09-15 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). The filing consists primarily of exhibits including graphics and XBRL data files. The actual substantive content of the disclosure cannot be determined from the index page alone; no dollar amounts, counterparties, transaction details, or concrete business developments are specified in the provided filing summary.
Why this rating
Index-only filing; no concrete substantive information disclosed. Cannot assess materiality without actual document content.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.